London, UK – 8th June 2022. Apposite Capital, the healthcare specialist private equity investor, today announces that it has made a further investment in Mirada Medical, a world leader in precision imaging software and image guided tools for cancer care. This investment brings total investment in Mirada since Apposite first invested in 2019 to c. $20m of new growth capital.
Click here to read the press release
Target – MIRADA MEDICAL LIMITED
Buyer – APPOSITE CAPITAL LLP
Seller – Shareholders